| Date Filed | Type | Description |
| 10/05/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/03/2022 |
4
| CHILDS JOHN W (Director) has filed a Form 4 on Biohaven Pharmaceutical Holding Co Ltd.|
Txns:
| Disposed/sold 3,025,001 shares
@ $148.5, valued at
$449.2M
Disposed/sold 10,000 shares
@ $148.5, valued at
$1.5M
Disposed/sold 8,239 options to buy
@ $0
Disposed/sold 11,996 options to buy
@ $0 |
|
| 10/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/03/2022 |
4
| Heffernan Michael Thomas (Director) has filed a Form 4 on Biohaven Pharmaceutical Holding Co Ltd.|
Txns:
| Disposed/sold 3,320 options to buy
@ $0
Disposed/sold 8,239 options to buy
@ $0
Disposed/sold 11,996 options to buy
@ $0
Disposed/sold 26,200 options to buy
@ $0 |
|
| 10/03/2022 |
4
| GREGORY JULIA P (Director) has filed a Form 4 on Biohaven Pharmaceutical Holding Co Ltd.|
Txns:
| Disposed/sold 8,239 options to buy
@ $0
Disposed/sold 11,996 options to buy
@ $0
Disposed/sold 18,000 options to buy
@ $0 |
|
| 10/03/2022 |
4
| JONES WILLIAM A JR (CCO-Migraine & Common Disease) has filed a Form 4 on Biohaven Pharmaceutical Holding Co Ltd.|
Txns:
| Disposed/sold 14,226 shares
@ $148.5, valued at
$2.1M
Disposed/sold 11,250 options to buy
@ $0
Disposed/sold 10,000 options to buy
@ $0
Disposed/sold 3,000 options to buy
@ $0
Disposed/sold 775 options to buy
@ $0
Disposed/sold 29,225 options to buy
@ $0
Disposed/sold 2,398 options to buy
@ $0
Disposed/sold 37,602 options to buy
@ $0
Disposed/sold 1,742 options to buy
@ $0
Disposed/sold 28,258 options to buy
@ $0
Disposed/sold 5,913 options to buy
@ $0 |
|
| 10/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/03/2022 |
4
| HUGIN ROBERT J (Director) has filed a Form 4 on Biohaven Pharmaceutical Holding Co Ltd.|
Txns:
| Disposed/sold 2,900 shares
@ $148.5, valued at
$430.7k
Disposed/sold 3,417 options to buy
@ $0
Disposed/sold 8,239 options to buy
@ $0
Disposed/sold 11,996 options to buy
@ $0
Disposed/sold 18,948 options to buy
@ $0 |
|
| 10/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/03/2022 |
4
| Bailey Gregory (Director) has filed a Form 4 on Biohaven Pharmaceutical Holding Co Ltd.|
Txns:
| Disposed/sold 2,583,658 shares
@ $148.5, valued at
$383.7M
Disposed/sold 8,239 options to buy
@ $0
Disposed/sold 11,996 options to buy
@ $0
Disposed/sold 18,000 options to buy
@ $0 |
|
| 10/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/28/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 08/22/2022 |
4
| Bailey Gregory (Director) has filed a Form 4 on Biohaven Pharmaceutical Holding Co Ltd.|
Txns:
| Bought 38,000 shares
@ $148.0441, valued at
$5.6M
|
|
| 05/12/2022 |
4
| Clark George C. (VP, Chief Accounting Officer) has filed a Form 4 on Biohaven Pharmaceutical Holding Co Ltd.|
Txns:
| Sold 4,200 shares
@ $141.5, valued at
$594.3k
Exercised 2,250 options to buy
@ $53.76, valued at
$121k
|
|
| 05/12/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/11/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 04/29/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/29/2022 |
4
| GREGORY JULIA P (Director) has filed a Form 4 on Biohaven Pharmaceutical Holding Co Ltd.|
Txns:
| Granted 8,239 options to buy
@ $97.74, valued at
$805.3k
|
|
| 04/29/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/29/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/29/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/29/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/11/2022 |
4/A
| Doogan Declan (Director) has filed a Form 4 on Biohaven Pharmaceutical Holding Co Ltd.|
Txns:
| Sold 2,464 shares
@ $67.8274, valued at
$167.1k
Sold 13,334 shares
@ $68.1523, valued at
$908.7k
Sold 15,508 shares
@ $68.5828, valued at
$1.1M
Sold 10,000 shares
@ $68.97, valued at
$689.7k
|
|
| 02/11/2022 |
4/A
| Doogan Declan (Director) has filed a Form 4 on Biohaven Pharmaceutical Holding Co Ltd.|
Txns:
| Sold 11,706 shares
@ $64.4221, valued at
$754.1k
Sold 13,333 shares
@ $64.7077, valued at
$862.7k
Sold 12,580 shares
@ $65.5513, valued at
$824.6k
Sold 13,334 shares
@ $66.0053, valued at
$880.1k
|
|
| 01/24/2022 |
4
| Clark George C. (VP, Chief Accounting Officer) has filed a Form 4 on Biohaven Pharmaceutical Holding Co Ltd.|
Txns:
| Sold 3,196 shares
@ $114.9293, valued at
$367.3k
Sold 2,159 shares
@ $116.0189, valued at
$250.5k
Sold 500 shares
@ $118.048, valued at
$59k
Sold 3,520 shares
@ $119.3694, valued at
$420.2k
Exercised 3,750 options to buy
@ $53.76, valued at
$201.6k
Exercised 1,920 options to buy
@ $32.42, valued at
$62.2k
|
|
| 01/12/2022 |
4
| Clark George C. (VP, Chief Accounting Officer) has filed a Form 4 on Biohaven Pharmaceutical Holding Co Ltd.|
Txns:
| Paid exercise price by delivering 464 shares
@ $128.87, valued at
$59.8k
Exercised 1,000 options to buy
@ $0 |
|
| 01/12/2022 |
4
| Stock Elyse (Chief Medical Officer) has filed a Form 4 on Biohaven Pharmaceutical Holding Co Ltd.|
Txns:
| Exercised 937 options to buy
@ $0 |
|
| 01/12/2022 |
4
| Mehta Kishan (Director) has filed a Form 4 on Biohaven Pharmaceutical Holding Co Ltd.|
Txns:
| Exercised 1,875 options to buy
@ $0 |
|
|